Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Clinical trial NCT07075718 · RECRUITING
Trial details
- NCT number
- NCT07075718
- Sponsor
- Glaukos Corporation
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-12
- Primary completion
- 2028-03-01
- Enrollment
- 610
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.